Bioterrorism And Gene Editing: Can Crispr Tool Be Used As Biological Weapon In War?
By Himanshu Goenka,
IB Times
| 12. 14. 2016
Crispr is a tool that allows for genes to be edited, and has great potential in the treatment of a wide range of diseases, including some for which there is currently no known cure. It rose to prominence in 2015, when it was chosen as the breakthrough technology of the year by the American Association for the Advancement of Science, and became even better known in 2016 when scientists behind it were strong contenders for the Nobel Prize (which it finally didn’t win) and also appeared in Time magazine’s readers’ poll for the Person of the Year title.
Even as a legal battle is currently underway for the patent rights to Crispr (its Cas9 variant, to be specific), the technology is far from perfect right now — scientists are still working on making it more precise and the first human test involving a gene modified using Crispr took place only in October. And yet, it has made it to the list put together by U.S. intelligence agencies on national security threats.
However, in a somewhat surprising announcement in February 2016...
Related Articles
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Jay S. Kaufman, Los Angeles Review of Books | 09.27.2025
This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...